Koninklijke Philips NV (PHG) stock
PHGNYSEX-Ray Apparatus & Tubes & Related Irradiation ApparatusFiscal year ends December 31Also trades as RYLPF
$30.05−0.15 (-0.50%)
Close on Nov 12, 2026Market cap $28.94BP/E 29.0Yield –
Koninklijke Philips r&d expenses
Research and development expenses are spending on new products and technology.
For fiscal 2024 it was €1.70B, down 2.7% from the year before. Over ten years it grew 0.9% a year on average. The highest annual figure on record is €2.09B in fiscal 2021.
Annual r&d expenses
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2024 | Dec 31, 2025 | €1.70B | -2.7% |
| FY2023 | Dec 31, 2024 | €1.75B | -7.6% |
| FY2022 | Dec 31, 2023 | €1.89B | -9.6% |
| FY2021 | Dec 31, 2022 | €2.09B | +15.8% |
| FY2020 | Dec 31, 2021 | €1.81B | -0.9% |
| FY2019 | Dec 31, 2020 | €1.82B | +1.8% |
| FY2018 | Dec 31, 2019 | €1.79B | +1.8% |
| FY2017 | Dec 31, 2018 | €1.76B | -0.3% |
| FY2016 | Dec 31, 2017 | €1.76B | +5.7% |
| FY2015 | Dec 31, 2016 | €1.67B | +6.9% |
| FY2014 | Dec 31, 2015 | €1.56B | – |
See a number that looks wrong?